cabergoline has been researched along with Cardiac Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assayag, P; Bouchachi, A; Brailly-Tabard, S; Chanson, P; Kamenicky, P; Kuhn, E; Maione, L; Rozière, M; Salenave, S; Young, J | 1 |
| Arduc, A; Berker, D; Çiçekcioğlu, H; Demirci, N; Demirtaş, S; Doğan, BA; Güler, S; Tuna, MM | 1 |
2 other study(ies) available for cabergoline and Cardiac Diseases
| Article | Year |
|---|---|
Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study.
Topics: Acromegaly; Adolescent; Adult; Antineoplastic Agents; Apnea; Cabergoline; Comorbidity; Ergolines; Female; Follow-Up Studies; Heart Diseases; Human Growth Hormone; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Retrospective Studies; Somatostatin; Young Adult | 2015 |
Autoimmune Fibrotic Adverse Reactions in One-Year Treatment with Cabergoline for Women with Prolactinoma.
Topics: Adult; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; Heart Diseases; Humans; Prolactinoma; Prospective Studies; Pulmonary Fibrosis; Time Factors; Treatment Outcome; Young Adult | 2016 |